Sixteen crossbred (British × Continental; average unshrunk body weight = 507.9 kg; SD = 45.6 kg) beef heifers fed a steam-flaked corn-based finishing diet with melengestrol acetate (0.4 mg/heifer daily) included to suppress estrus were used in a completely random design to evaluate the efficacy of buccal administration of 0, 10, 100, or 1000 mg of 25-hydroxyvitamin D 3 , (25-OH D 3 ). Serum Ca, P, Mg, 25-OH D 3 , 1,25-dihydroxyvitamin D [1,25-(OH) 2 D 3 ], albumin, and protein were measured 24 h before dosing (−24 h), at dosing (0 h), and 6 and 24 h after dosing, after which the cattle were slaughtered at a commercial facility. Samples of kidneys, liver, longissimus lumborum, and triceps brachii were collected and evaluated for concentrations of 1,25-(OH) 2 D 3 . With −24 and 0 h as baseline covariates, a significant time × treatment interaction was observed for serum 25-OH D 3 and Ca concentrations, but not for serum 1,25-(OH) 2 D 3 . Supplemental 25-OH D 3 doses of 100 and 1000 mg significantly increased serum 25-OH D 3 at 24 h after dosing, 1,25-(OH) 2 D 3 at 6 and 24 h after dosing, and serum Ca at 24 h after dosing. Similarly, buccal dosing of 1000 mg of supplemental 25-OH D 3 significantly increased (approximately 2-to 3-fold) concentrations of 1,25-(OH) 2 D 3 in the kidney, liver, and longissimus lumborum relative to the other 3 treatments but not in triceps brachii. Serum albumin, protein, P, and Mg were not affected by treatment. Based on these results, buccal administration of 100 and 1000 mg 25-OH D 3 increased vitamin D 3 metabolites in serum and tissues, and it should be an effective method of delivering the vitamin. Dietary vitamin D is absorbed in the small intestine and hydroxylated in the liver to form 25-hydroxyvitamin D 3 (25-OH D 3 ), the major circulating form of the vitamin (Reinhart and Hustmyer, 1987), which is further hydroxylated in the kidney to form 1,25-dihydroxy vitamin D 3 (1,25-(OH) 2 D 3 ), the active form of the vitamin (Reinhart and Hustmyer, 1987.) The active form functions in Ca and P homeostasis (Hodnett et al., 1992) through mediation of parathyroid hormone (NRC, 1987) , immune system regulation (Reinhart and Hustmyer, 1987), and regulation of fluid balance by its effect on rennin and angiotensin II (Li, 2003) . Effects of supplemental vitamin D and various metabolites on parturient paresis in dairy cattle have been studied extensively (e.g., Hove et al., 1983; Hodnett et al., 1992.) Moreover, feeding high doses of vitamin D may improve tenderness of beef (Karges et al., 2001; Montgomery et al., 2000 Montgomery et al., , 2004b. Typically, vitamin D is supplemented in the diet or injected; however, variations in DMI may lead to less than optimal doses of the vitamin being consumed, and concerns regarding injection site lesions (Roeber et al., 2002) warrant examination of alternative delivery methods. Rivera et al. (2003) reported that oral drenching of vitamin E was as effective for administering the vitamin as subcutaneous injection for newly received, stressed beef cattle. Transmucosal delivery by the buccal route is an effective means of delivering various human medications (Cefalu, 2002; Belmin and Valensi, 2003.) Moreover, Okura et al. (2004) recently demonstrated effective absorption of 1,25-(OH) 2 D 3 after vaginal administration in Holstein heifers. Therefore, the objective of this experiment was to evaluate the efficacy of buccal administration of 25-OH D 3 in beef cattle. 25-Hydroxyvitamin D was chosen as the vitamin D source in this experiment because we hypothesized that buccal delivery of an active component of
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Sixteen British × Continental beef heifers were selected randomly from a pen of cattle at a commercial feedlot in Hereford, TX. The cattle had been on feed for approximately 120 d, and were scheduled to ship to slaughter in a few days. The live, unshrunk BW of the heifers was measured 4 times over the experimental period, and it averaged 507.9 kg (SD = 45.6 kg). The diet fed to the cattle was a typical finishing diet that consisted primarily of steam-flaked corn, animal fat, corn silage, alfalfa hay, and a protein/mineral supplement. The diet included melengestrol acetate (MGA; Pfizer Animal Health, Lees Summit, MO; 0.4 mg/heifer daily) to suppress estrus, and it supplied Rumensin and Tylan (Elanco Animal Health, Indianapolis, IN) at manufacturer's suggested concentrations (approximately 27.5 to 33 mg/kg and 8.8 to 11 mg/kg, respectively), with CP and NEg concentrations (DM basis) of approximately 13.5% and 1.52 Mcal/kg, respectively. The heifers were assigned randomly to 1 of 4 treatments: 1) 1 mL of a propylene glycol (PG) solution (0); 2) 1 mL of a PG solution that contained 10 mg of 25-OH D 3 (10); 3) 1 mL of a PG solution that contained 100 mg of 25-OH D 3 (100); or 4) 10 mL of a PG solution that contained 100 mg of 25-OH D 3 /mL (1000). Treatments were administered by restraining the animal in a squeeze chute and discharging the appropriate dose for each of the 4 treatments into the side of the mouth (cheek area; a 3-mL syringe was used for the 0, 10-, and 100-mg treatments, and a 10-mL syringe was used for the 1000-mg treatment). Following administration of 25-OH D 3 , the heifers were group-housed in a soilsurfaced pen, with ad libitum access to feed and water. The heifers were observed at 0, 1, 2, 6, and 12 h for adverse effects. Blood was collected via jugular venipuncture using vacuum tubes 24 h before dosing (−24 h), at dosing (0 h), and at 6 and 24 h after dosing. Blood samples were allowed to clot and then centrifuged at approximately 1000 × g for 15 min, after which serum was decanted and stored frozen for subsequent analysis of Ca, P, Mg, albumin, protein, , and 1,25-(OH) 2 D 3 . Following the last sample collection, the cattle were shipped approximately 10 km to a commercial slaughter facility. Both kidneys, along with the liver, lungs, heart, adrenal glands, and parathyroid tissues were obtained at slaughter. Following a 48-h chill, tissue samples from the longissimus lumborum and triceps brachii were collected. Carcasses of the heifers 125 I Kit, catalog no. 65100E; DiaSorin, Inc., Stillwater, MN). Extraction of samples and performance of the vitamin D metabolite assays were done in accordance with the manufacturer's protocols. When 3 different quantities of 25-OH D 3 were added to each of 5 serum samples before extraction, an average of 103% was recovered in the assay. In serum pools with concentrations of 25-OH D 3 of 61 and 161 nmol/ L, the respective intraassay CV were 9.1 and 8.7%, and interassay CV were 13 and 13% (10 assays), respectively. When 3 different quantities of 1,25-(OH) 2 D 3 were added to each of 5 serum pools, an average of 94% was measured in the assay. In control sera, with concentrations of 1,25-(OH) 2 D 3 of 50 and 155 pmol/L, the respective intraassay CV were 9.9 and 5.5%, and interassay CV were 19.9 and 23.6% (13 assays). Concentrations of 1,25-OH 2 D 3 in liver, kidneys, longissimus lumborum, and triceps brachii were analyzed at the Periparturient Diseases of Cattle Research Unit, National Animal Disease Center, Ames, IA, according to procedures described by Montgomery et al. (2000) . Serum Ca, P, Mg, albumin, protein (spectrophotometric procedures), and histopathology on liver, lung, kidney, heart, adrenal, and parathyroid were analyzed at the Texas Veterinary Diagnostic Laboratory in Amarillo, TX. This laboratory is accredited by the American Association of Veterinary Laboratory Diagnosticians.
Serum constituents were analyzed as a completely random design repeated over time (6 and 24 h after dosing) with PROC MIXED (SAS Inst., Inc., Cary, NC). Serum data collected at −24 and 0 h were included in the model as baseline covariates. Preplanned comparisons (0 vs. 10; 0 vs. 100; and 0, 10, and 100 vs. 1000) were conducted using contrast statements in PROC MIXED. When a time × treatment interaction was detected (P < 0.05), preplanned comparisons were evaluated within time period; otherwise, contrasts of means averaged over time were evaluated. Tissue concentrations were analyzed as a completely random design using PROC GLM, with the same preplanned contrasts used for serum data.
No symptoms of toxicity were evident in the cattle. Similarly, no soft tissue ossification was noted at the time of slaughter, and histopathology on liver, lung, kidney, heart, adrenal, and parathyroid indicated no gross abnormalities (data not shown).
Data for serum 25-OH D 3 and 1,25-(OH) 2 D 3 concentrations are presented in Tables 1 and 2 , respectively. Time relative to administration of 25-OH D 3 . Times −24 and 0 h were used as baseline covariates in the repeated measures analysis of 6-and 24-h data. Sampling time × treatment interaction (P < 0.001) for samples collected at 6 and 24 h. 4 Pooled standard error of the treatment means for −24-and 0-h samples. Covariance-adjusted pooled standard errors for samples collected at 6 and 24 h were 15.2, 15.2, 14.8, and 15.1 ng/mL for the 0, 10, 100, and 1000 mg treatments, respectively.
A time × treatment interaction (P < 0.001) was observed for serum 25-OH D 3 data, but not for serum 1,25-(OH) 2 D 3 data (P ≥ 0.33); however, for consistency of presentation, means within each time period are reported for both variables. The 100-mg dose of 25-OH D 3 increased (P = 0.001) serum 25-OH D 3 at 24 h after dosing, whereas the 1000-mg dose increased (P = 0.001) serum 25-OH D 3 at both 6 and 24 h after dosing compared with the other treatments, with the peak at 404.5 ng/ mL at 24 h. No differences (P ≥ 0.34) were noted between cattle receiving the 0 and 10 mg treatments for serum 25-OH D 3 concentrations at either time after dosing. Littledike and Horst (1982) reported an increase in plasma 25-OH D 3 when cattle were administered 15 × 10 6 IU of vitamin D 3 on d 0 followed by a second injection of a lesser concentration 7 d later.
As expected with the increase in 25-OH D 3 in the present study, serum 1,25-(OH) 2 D 3 increased (P = 0.001 to 0.006) at 6 and 24 h after dosing for both the 100 and 1000 doses, with a peak at 165.7 pg/mL 24 h Time relative to administration of 25-OH D 3 . Sampling times −24 and 0 h were used as baseline covariates in the repeated measures analysis of 6-and 24-h data. The sampling time × treatment interaction was not significant (P ≥ 0.33) for samples collected at 6 and 24 h. 4 Pooled standard error of the treatment means for −24-and 0-h samples. Covariance-adjusted pooled standard errors for samples collected at 6 and 24 h were 15.6, 15.7, 16.2, and 15.5 pg/mL for the 0, 10, 100, and 1000 mg treatments, respectively.
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after dosing when cattle were administered 1000 mg of 25-OH D 3 (Table 2 ). In contrast to results with serum concentrations of 25-OH D 3 , the 10-mg dose tended (P = 0.06) to increase serum 1,25-(OH) 2 D 3 at 24 h after dosing compared with control. 25-Hydroxyvitamin D 3 is metabolized by the kidney to 1,25-(OH) 2 D 3 , which is the form required for Ca absorption (NRC, 1987) . Previous research has shown that both feeding and injecting 25-OH D 3 and 1,25-(OH) 2 D 3 increase serum and plasma concentrations of these metabolites. Hove et al. (1983) reported peak plasma 1,25-(OH) 2 D 3 at 200 pg/mL when cattle were fed 500 µg of 1,25-(OH) 2 D 3 in a pelleted form mixed into a daily ration, whereas an i.m. injection of 1,25-(OH) 2 D 3 resulted in a peak concentration of approximately 1000 pg/mL within 12 h. Likewise, when Hodnett et al. (1992) injected 0.5 mg of 1-α (OH) 2 D 3 and 4 mg of 25-OH D 3 into dairy cattle, serum 1,25-(OH) 2 D 3 peaked at 125 pg/mL. These data demonstrate that buccal administration is an effective route to rapidly increase serum concen- Time relative to administration of 25-OH D 3 . Sampling times −24 and 0 h were used as baseline covariates in the repeated measures analysis of 6-and 24-h data. The sampling time × treatment interaction was significant (P < 0.003) for samples collected at 6 and 24 h. . Some of the dose could have been swallowed by the animals, and with blood samples collected only at 6 and 24 h after dosing, it is not possible to distinguish between mucosal and gastrointestinal absorption. Moreover, it is possible that 10 mL of propylene glycol as a carrier for the 1000-mg dose might have stimulated swallowing by heifers in that treatment group compared with the 1-mL volume used in the other 3 groups. Thus, additional research is needed to determine whether increases in serum vitamin D metabolites as observed resulted solely from mucosal transfer of 25-OH D 3 or from a combination of mucosal transfer and gastrointestinal absorption.
Administration of 100 and 1000 mg of 25-OH D 3 increased (P = 0.04 and 0.001, respectively) serum Ca at 24 h after dosing (Table 3) , but the 10-mg dose had little effect on serum Ca. These increases in serum Ca coincided with periods when 1,25-(OH) 2 D 3 was increased by the 100-and 1000-mg doses (Table 2) No treatment × sampling time interactions were detected (P ≥ 0.14) for serum albumin, protein, P, and Mg, and main-effect means for samples collected 6 and 24 h after dosing are shown in Table 4 . Neither serum albumin nor protein differed (P ≥ 0.17) among treatments. Albumin is required to transport various serum constituents, and Yamaguchi et al. (2003) reported an increase in albumin in bone fractures of rats, which led to an increase in serum Ca. The results noted by Yamaguchi et al. (2003) were related to a need for bonestimulating factors associated with fractures, whereas the cattle in the current study had no such requirement. Serum P concentration tended (P = 0.09) to be increased with the 1000-mg dose of 25-OH D 3 vs. the other treatments, but no differences (P ≥ 0.26) were observed among treatments for serum Mg concentrations (Table  4) . Montgomery et al. (2004a) reported that feeding vitamin D at 1 and 5 million IU (/steer per d) for 8 d before slaughter increased serum P concentrations relative to controls, but Karges et al. (2001) reported no differences in serum P following vitamin D supplementation for 4 or 6 d. In contrast to our results, however, Karges et al. (2001) noted a numerical decrease in serum Mg concentration following supplementation. Moreover, Hove et al. (1983) reported a decrease in Mg following treatment with vitamin D metabolites either orally or as an i.m. injection. That serum Mg failed to respond to increasing 25-OH D 3 concentrations in the present study might reflect the duration of treatment. The cattle used by Karges et al. (2001) were administered the vitamin for 4 or 6 d, whereas the cattle in our study were given 25-OH D 3 only once. Similarly, Hove et al. (1983) sampled for a longer period than in our study. Levine et al. (1980) reported that serum Mg de- Pooled standard error of the treatment means; n = 8 for serum variables, and n = 4 for tissue concentrations. For serum data, the largest SE value among the 4 covariance-adjusted means is reported.
3
No sampling time × treatment interactions (P ≥ 0.14) were observed for serum data collected 6 and 24 h after treatment. Samples collected 24 and 0 h before treatment were used as baseline covariates (−24-and 6-h data not shown).
creased in vitamin D-deficient rats given injections of 1,25-(OH) 2 D 3 , but only after 5 to 8 d of treatment. Perhaps sampling for a longer period following administration with 25-OH D 3 than was done in the present study might have increased the likelihood of detecting changes in serum Mg.
Compared with the other 3 treatments, 1000 mg of buccally administered 25-OH D 3 increased (P ≤ 0.01) concentrations of 1,25-(OH) 2 D 3 in the kidneys, liver, and longissimus lumborum. Conversely, concentrations of 1,25-(OH) 2 D 3 in triceps brachii muscle were not affected by any dose of 25-OH D 3 (P ≥ 0.11). The 100-mg dose increased (P = 0.003) the concentration of 1,25-(OH) 2 D 3 in the longissimus sample, and the 10-mg dose tended (P = 0.09) to increase kidney concentrations of 1,25-(OH) 2 D 3 . Montgomery et al. (2000) reported increased 1,25-(OH) 2 D 3 in top round steaks of cattle fed 7.5 × 10 6 IU/d for 9 d before slaughter, but observed no significant increases in concentrations of 1,25-(OH) 2 D 3 in the kidneys, liver, or strip loin steaks. Similarly, Montgomery et al. (2004b) reported that liver, kidney, and longissimus muscle concentrations of 1,25-(OH) 2 D 3 in beef steers were generally not affected by feeding 0, 0.5, 1, and 5 million IU (/steer per d) for 8 d before slaughter. Although more research is needed, it seems that feeding high doses of vitamin D 3 might have different effects on tissue concentrations of 1,25-(OH) 2 D 3 than buccal dosing of 25-OH D 3 . Olson et al. (1974) conducted experiments to determine whether prolonged oral or injected 25-OH D 3 would result in high vitamin D activity in milk and tissue, and concluded that doses of 25-OH D 3 that would decrease the incidence of parturient paresis would not affect the safety of products from treated animals. The concentrations of 25-OH D 3 in the longissimus and triceps samples in the present study were within range of the values observed by Olson et al. (1974) .
Based on our results, buccal dosing seems to be a valid method to deliver 25-OH D 3 to cattle. This method of dosing would allow for administration of the vitamin before slaughter or at other times when supplemental vitamin D is needed without causing injection site lesions at slaughter. Further research is needed to determine how long the concentrations of 25-OH D 3 remain elevated following buccal administration, to determine whether similar results would be observed with other vitamins, and to compare blood and tissue concentrations in cattle dosed by the buccal route with more commonly used routes (e.g., i.m. injection, feeding).
